×

Our award-winning reporting has moved

Context provides news and analysis on three of the world’s most critical issues:

climate change, the impact of technology on society, and inclusive economies.

GlaxoSmithKline settles fraud charges for ${esc.dollar}3 bln

by Reuters
Monday, 2 July 2012 14:44 GMT

WASHINGTON, July 2 (Reuters) - GlaxoSmithKline Plc has agreed to plead guilty to criminal charges and pay ${esc.dollar}3 billion to settle the largest case of healthcare fraud in U.S. history, according to court filings and prosecutors.

The settlement includes ${esc.dollar}1 billion in criminal fines and ${esc.dollar}2 billion in civil fines in connection with the sale of the drug company's Paxil, Wellbutrin and Avandia products.

Our Standards: The Thomson Reuters Trust Principles.

-->